top
GLIOBLASTOMA NEWSLETTER
Volume 1, Number 12 - 30 October 2002

Volume 1
Archive


THE REFERENCES FROM THE BOOK "SURVIVAL 'TERMINAL' CANCER" BY BEN WILLIAMS

Chapter 3 - Improving My Odds for Survival
1 Levin VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, Wilson CB
Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas
Int J Radiat Oncol Biol Phys 1995 Apr 30;32(1):75-83 (
Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7721642&dopt=Abstract

2 Figueredo A, Arnold A, Goodyear M, Findlay B, Neville A, Normandeau R, Jones A
Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer. A phase I/II study
Cancer 1990 May 1;65(9):1895-902 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2164872&dopt=Abstract

3 Bowles AP Jr, Pantazis CG, Wansley W
Use of verapamil to enhance the antiproliferative activity of BCNU in human glioma cells: an in vitro and in vivo study
J Neurosurg 1990 Aug;73(2):248-53 (Cell Culture Study | Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2366081&dopt=Abstract

4 Aas AT, Brun A, Pero RW, Salford LG.
Chlorpromazine in combination with nitrosourea inhibits experimental glioma growth
Br J Neurosurg 1994;8(2):187-92 (Cell Culture Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7917090&dopt=Abstract

5 N.A.
6 N.A.

7 Murovic J, Turowski K, Wilson CB, Hoshino T, Levin V
Computerized tomography in the prognosis of malignant cerebral gliomas
J Neurosurg 1986 Dec;65(6):799-806 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3021932&dopt=Abstract


8 Lissoni P, Meregalli S, Nosetto L, Barni S, Tancini G, Fossati V, Maestroni G.
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone
Oncology 1996 Jan-Feb;53(1):43-6 (
Clinical Study, Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8570130&dopt=Abstract

9 Das UN, Prasad VV, Reddy DR
Local application of gamma-linolenic acid in the treatment of human gliomas
Cancer Lett 1995 Aug 1;94(2):147-55 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7634242&dopt=Abstract

Chapter 4 - Salvaging a Life
N.A.

Chapter 5 - Toward a Rational Treatment Strategy
1 Rowlands MG, Budworth J, Jarman M, Hardcastle IR, McCague R, Gescher A
Comparison between inhibition of protein kinase C and antagonism of calmodulin by tamoxifen analogues

Biochem Pharmacol 1995 Aug 25;50(5):723-6
(Cell Culture Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7669076&dopt=Abstract

2 N.A.
3 N.A.
4 N.A.
5 N.A.

6 HA Fine, JS Loeffler, A Kyritsis, P Wen, PM Black, VA Levin, S Graham, WKA Yung
A phase II trial of the anti-angiogenic agent, thalidomide, in patients with recurrent high-grade gliomas

ASCO Proceedings, 1997 Annual Meeting, Abstract No. 1372 (Clinical Study)
Source: http://www.asco.org/asco/ascoMainConstructor/1,1003,_12-002328,00.asp

7 Jo Glass, Gruber Michael , Anit Nirenberg
Phase I/II Study of Carboplatin and Thalidomide in Recurrent Glioblastoma Multiforme

ASCO Proceedings, 1999 Annual Meeting, Abstract
No. 551 (Clinical Study)
Source: http://www.asco.org/asco/ascoMainConstructor
/1,47468,_12|002326|00_29|00A|00_18|001999|00_19|0014804,00.asp


Chapter 6 - Shared Experiences
1 N.A.
2 N.A.
3 Plowman J, Waud WR, Koutsoukos AD, Rubinstein LV, Moore TD, Grever MR
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea
Cancer Res 1994 Jul 15;54(14):3793-9 (Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8033099&dopt=Abstract

4 Newlands ES, O'Reilly SM, Glaser MG, Bower M, Evans H, Brock C, Brampton MH, Colquhoun I, Lewis P, Rice-Edwards JM, Illingworth RD, Richards PG.
The Charing Cross Hospital experience with temozolomide in patients with gliomas

Eur J Cancer 1996 Dec;32A(13):2236-41
(Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9038604&dopt=Abstract

 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BL Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP